203 related articles for article (PubMed ID: 19118015)
1. Identification of novel alternative splice isoforms of circulating proteins in a mouse model of human pancreatic cancer.
Menon R; Zhang Q; Zhang Y; Fermin D; Bardeesy N; DePinho RA; Lu C; Hanash SM; Omenn GS; States DJ
Cancer Res; 2009 Jan; 69(1):300-9. PubMed ID: 19118015
[TBL] [Abstract][Full Text] [Related]
2. Proteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancers.
Menon R; Omenn GS
Cancer Res; 2010 May; 70(9):3440-9. PubMed ID: 20388783
[TBL] [Abstract][Full Text] [Related]
3. Alternative splice variants, a new class of protein cancer biomarker candidates: findings in pancreatic cancer and breast cancer with systems biology implications.
Omenn GS; Yocum AK; Menon R
Dis Markers; 2010; 28(4):241-51. PubMed ID: 20534909
[TBL] [Abstract][Full Text] [Related]
4. Novel protein isoforms of carcinoembryonic antigen are secreted from pancreatic, gastric and colorectal cancer cells.
Hatakeyama K; Wakabayashi-Nakao K; Ohshima K; Sakura N; Yamaguchi K; Mochizuki T
BMC Res Notes; 2013 Sep; 6():381. PubMed ID: 24070190
[TBL] [Abstract][Full Text] [Related]
5. Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
Doyle GA; Rebecca Sheng X; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
Gene; 2007 Feb; 388(1-2):135-47. PubMed ID: 17156941
[TBL] [Abstract][Full Text] [Related]
6. Detection of alternative splice variants at the proteome level in Aspergillus flavus.
Chang KY; Georgianna DR; Heber S; Payne GA; Muddiman DC
J Proteome Res; 2010 Mar; 9(3):1209-17. PubMed ID: 20047314
[TBL] [Abstract][Full Text] [Related]
7. Alternate splicing at the 3'-end of the human pancreatic tumor-associated mucin MUC4 cDNA.
Choudhury A; Moniaux N; Ringel J; King J; Moore E; Aubert JP; Batra SK
Teratog Carcinog Mutagen; 2001; 21(1):83-96. PubMed ID: 11135323
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer.
Arafat H; Lazar M; Salem K; Chipitsyna G; Gong Q; Pan TC; Zhang RZ; Yeo CJ; Chu ML
Surgery; 2011 Aug; 150(2):306-15. PubMed ID: 21719059
[TBL] [Abstract][Full Text] [Related]
9. Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.
Mirus JE; Zhang Y; Hollingsworth MA; Solan JL; Lampe PD; Hingorani SR
Mol Cell Proteomics; 2014 Dec; 13(12):3484-96. PubMed ID: 25225358
[TBL] [Abstract][Full Text] [Related]
10. Plasma proteomics, the Human Proteome Project, and cancer-associated alternative splice variant proteins.
Omenn GS
Biochim Biophys Acta; 2014 May; 1844(5):866-73. PubMed ID: 24211518
[TBL] [Abstract][Full Text] [Related]
11. Alternatively Spliced Homologous Exons Have Ancient Origins and Are Highly Expressed at the Protein Level.
Abascal F; Ezkurdia I; Rodriguez-Rivas J; Rodriguez JM; del Pozo A; Vázquez J; Valencia A; Tress ML
PLoS Comput Biol; 2015 Jun; 11(6):e1004325. PubMed ID: 26061177
[TBL] [Abstract][Full Text] [Related]
12. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
[TBL] [Abstract][Full Text] [Related]
13. Comparative proteomics reveals a significant bias toward alternative protein isoforms with conserved structure and function.
Ezkurdia I; del Pozo A; Frankish A; Rodriguez JM; Harrow J; Ashman K; Valencia A; Tress ML
Mol Biol Evol; 2012 Sep; 29(9):2265-83. PubMed ID: 22446687
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models.
Ligat L; Saint-Laurent N; El-Mrani A; Gigoux V; Al Saati T; Tomasini R; Nigri J; Dejean S; Pont F; Baer R; Guillermet-Guibert J; Cordelier P; Lopez F; Dufresne M
Br J Cancer; 2015 Dec; 113(11):1590-8. PubMed ID: 26512875
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell splice variants of the transcription factor TEF-1 induced by SV40 T-antigen transformation.
Zuzarte PC; Farrance IK; Simpson PC; Wildeman AG
Biochim Biophys Acta; 2000 Dec; 1517(1):82-90. PubMed ID: 11118619
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel protein isoform derived from cancer-related splicing variants using combined analysis of transcriptome and proteome.
Hatakeyama K; Ohshima K; Fukuda Y; Ogura S; Terashima M; Yamaguchi K; Mochizuki T
Proteomics; 2011 Jun; 11(11):2275-82. PubMed ID: 21548097
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq.
Zhang F; Deng CK; Wang M; Deng B; Barber R; Huang G
BMC Bioinformatics; 2020 Dec; 21(Suppl 9):541. PubMed ID: 33272210
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles of pancreatic cancer and stromal desmoplasia.
Crnogorac-Jurcevic T; Efthimiou E; Capelli P; Blaveri E; Baron A; Terris B; Jones M; Tyson K; Bassi C; Scarpa A; Lemoine NR
Oncogene; 2001 Nov; 20(50):7437-46. PubMed ID: 11704875
[TBL] [Abstract][Full Text] [Related]
19. Novel splice variants in the 5'UTR of Gtf2i expressed in the rat brain: alternative 5'UTRs and differential expression in the neuronal dendrites.
Shirai Y; Watanabe M; Sakagami H; Suzuki T
J Neurochem; 2015 Aug; 134(3):578-89. PubMed ID: 25913238
[TBL] [Abstract][Full Text] [Related]
20. Cloning of a third member of the D52 gene family indicates alternative coding sequence usage in D52-like transcripts.
Nourse CR; Mattei MG; Gunning P; Byrne JA
Biochim Biophys Acta; 1998 Nov; 1443(1-2):155-68. PubMed ID: 9838088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
